Clinical and Pathologic Studies in Scleromyxedema

Overview

About this study

This study is being conducted in order to better understand the biology of scleromyxedema in hope of discovering markers that might give diagnostic and prognostic information, as well as potentially developing more effective therapies in the future.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of scleromyxedema

Exclusion Criteria:

  • Unable to provide informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Pittelkow, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20315404

Mayo Clinic Footer